ClinConnect ClinConnect Logo
Search / Trial NCT01429714

The Ideal Deep Venous Thrombosis (DVT) Study

Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Sep 6, 2011

Trial Information

Current as of April 29, 2025

Completed

Keywords

Elastic Compression Stockings Deep Venous Thrombosis Post Thrombotic Syndrome

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Legal age (18 yrs)
  • Informed consent
  • Acute objectively documented DVT of the leg
  • Adequate anticoagulation
  • Exclusion Criteria:
  • Previous DVT in the affected leg
  • Recurrent DVT in the first 6 months following inclusion
  • Preexistent venous insufficiency (skin signs C4-C6 on CEAP score or requiring ECS therapy)
  • Contraindication for elastic compression therapy (arterial insufficiency)
  • Active thrombolysis
  • Life expectancy \< 6 months

About Maastricht University Medical Center

Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.

Locations

Heerlen, , Netherlands

Padua, , Italy

Amsterdam, , Netherlands

Maastricht, , Netherlands

Treviso, , Italy

Almere, , Netherlands

Amsterdam, , Netherlands

Amsterdam, , Netherlands

Amsterdam, , Netherlands

Eindhoven, , Netherlands

Groningen, , Netherlands

Hoorn, , Netherlands

Nijmegen, , Netherlands

Roermond, , Netherlands

Patients applied

0 patients applied

Trial Officials

Arina J ten Cate-Hoek, MD, PhD, MpH

Principal Investigator

Maastricht University Medical Centre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials